TP53 and colorectal carcinoma: Analysis of TP53 expression data from The Cancer Genome Atlas (TCGA) also revealed that patients with lower TP53-expressing CRC tended to show unfavorable survival (p = 0.17; Supplementary Figure S3a); however, it was considered that TP53 expression levels and p53 immunoreactivity would not be parallel.